Information Journal Paper
APA:
CopyTEPEL, M., VAN DER GIET, M., STATZ, M., JANKOWSKI, J., & ZIDEK, W.. (2003). THE ANTIOXIDANT ACETYLCYSTEINE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE RENAL FAILURE: A RANDOMIZED, CONTROLLED TRIAL. CIRCULATION JOURNAL, 107(-), 992-995. SID. https://sid.ir/paper/548610/en
Vancouver:
CopyTEPEL M., VAN DER GIET M., STATZ M., JANKOWSKI J., ZIDEK W.. THE ANTIOXIDANT ACETYLCYSTEINE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE RENAL FAILURE: A RANDOMIZED, CONTROLLED TRIAL. CIRCULATION JOURNAL[Internet]. 2003;107(-):992-995. Available from: https://sid.ir/paper/548610/en
IEEE:
CopyM. TEPEL, M. VAN DER GIET, M. STATZ, J. JANKOWSKI, and W. ZIDEK, “THE ANTIOXIDANT ACETYLCYSTEINE REDUCES CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE RENAL FAILURE: A RANDOMIZED, CONTROLLED TRIAL,” CIRCULATION JOURNAL, vol. 107, no. -, pp. 992–995, 2003, [Online]. Available: https://sid.ir/paper/548610/en